Manganese neurotoxic time course is not influenced by l-deprenyl systemic treatment. Influence of l-deprenyl in manganese neurotoxic time course

Brain Research

Volumn 1317, Issue , 2010, Pages 277-285

  Fernandes, Artur ^a   de Oliveira, Eduardo Fontana ^a   de Rezende, Isabel Cristina Vicente ^a   Ponzoni, Silvia ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Apomorphine; l deprenyl; Manganese chloride; Neurotoxicity; Rotational behavior; Tyrosine hydroxylase

Indexed keywords

APOMORPHINE; MANGANESE; SELEGILINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; BODY POSTURE; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; DRUG DOSE REGIMEN; DRUG TREATMENT FAILURE; IMMUNOHISTOCHEMISTRY; MALE; MICROINJECTION; NEUROPROTECTION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; SYSTEMIC THERAPY;

ANIMALS; APOMORPHINE; CORPUS STRIATUM; DOPAMINE AGONISTS; IMMUNOHISTOCHEMISTRY; MALE; MANGANESE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; PHOTOMICROGRAPHY; RATS; ROTATION; SELEGILINE; SUBSTANTIA NIGRA; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

RATTUS;

EID: 75849128549     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.12.066     Document Type: Article

References (35)

1. Biagini G., Ferraguti F., Ponzoni S., Zoli M., Alboni L., Toffano G., Fuxe K., and Agnati L.F. Neurochemical and behavioral studies on L-DOPA toxicity in the model of manganese lesioned nigrostriatal pathway in the rat: evidence for a protective effect of the GM1 lactone siagoside. In: Fuxe K., Agnati L.F., Bjelke B., and Ohoson D. (Eds). Wenner-Gren Symposium on Trophic Regulation of the Basal Ganglia: Focus on Dopamine Neurons (1994) 381-407
2. Carman L.S., Cage F.H., and Shults C.W. Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res. 553 (1991) 275-283
3. Chu N.S., Hochberg F.H., Calne D.B., and Olanow C.W. Neurotoxicology of manganese. Handbook of Neurotoxicology (1995) 91-101
4. Costall B., Marsden C.D., Nayllor R.J., and Pycock J. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain. Brain Res. 118 (1976) 87-113
5. Cotzias G.C. Manganese in health and disease. Physiol. Rev. 38 (1958) 503-532
6. Desole M.S., Sciola L., Delogu M.R., Sircana S., Migheli R., and Miele E. Role of oxidative stress in the manganese and 1-methyl-4-(2′-ethylphenyl)-1, 2, 3, 6-tetrahydropyridine-induced apoptosis in PC112 cells. Neurochem. Int. 31 2 (1997) 169-176
7. Donaldson J. The physiopathologic significance of manganese in brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 8 (1987) 451-462
8. Gerlach M., Youdim M.B.H., and Riederer P. Pharmacology of selegiline. Neurology 47 Suppl. 3 (1996) S137-S145
9. Gomes M.Z., and Del Bel E.A. Effects of electrolytic and 6-hydroxydopamine lesions of rat nigrostriatal pathway on nitric oxide synthase and nicotinamide adenine dinucleotide phosphate diaphorase. Brain Res. Bull. 62 (2003) 107-115
10. Gorell J.M., Johnson C.C., Rybick B.A., Peterson E.L., and Richardson R.J. The risk of Parkinson's disease with exposure to pesticides, farming, well water and rural living. Neurology 50 (1998) 1346-1350
11. Hazell A.S. Astrocytes and manganese neurotoxicity. Neurochem. Int. 41 (2002) 271-277
12. Hazell A.S., Desjardins P., and Butterworth R.F. Increased expression of glyceraldehydes-3-phosphate dehydrogenase in cultured astrocytes following exposure to manganese. Neurochem. Int. 35 (1999) 11-17
13. Iczkiewicz J., Rose S., and Jenner P. Osteopontin expression in activated glial cells following mechanical- or toxin-induced nigral dopaminergic cells loss. Exp. Neurol. (2007) 95-106
14. Kalia K., Jiang W., and Zheng W. Manganese accumulates primarily in nuclei in cultured brain cells. Neurotoxicol. 29 (2008) 466-470
15. Kumar M.V.S., and Desiraju T. Effects of chronic manganese exposure on rat brain regional biogenic amines and GABA/glutamate system. Biog. Amines 8 (1992) 79-83
16. Lamensdorf L., and Finberg J.P.M. Reduced striatal tyrosine hydrohylase activity is not accompanied by change in responsiveness of dopaminergic receptors following chronic treatment with deprenyl. Neuropharmacology 36 10 (1997) 1455-1461
17. Meco G., Bonifati V., Vanacore N., and Fabrizio E. Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate). Scand. J. Work Environ. Health 20 (1994) 301-305
18. Morello M., Canini A., Mattioli P., Sorge R.P., Alimonti A., Bocca B., Forte G., Martorana A., Bernardi G., and Sancesario G. Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats an electron spectroscopy imaging and electron energy-loss spectroscopy study. Neurotoxicol. 29 (2008) 60-72
19. Parenti M., Flauto C., Parati E., Vescovi A., and Groppetti A. Manganese neurotoxicity effects on L-dopa and pargyline treatments. Brain Res. 367 (1986) 8-13
20. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1982), Academic Press, London
21. Ponzoni S., Guimarães F., DelBel E.A., and Cairasco N.G. Behavioral effects of intra nigral microinjection of manganese chloride: interaction with nitric oxide. Prog. Neuropsychopharmacol. Biol. Psychiatry 24 (2000) 307-325
22. Ponzoni S., Gaziri L.C.J., Britto L.R.G., Barreto W.J., and Blum D. Clearance of manganese from the rat substantia nigra following intra-nigral microinjections. Neurosci. Lett. 328 (2002) 170-174
23. Quintanar L. Manganese neurotoxicity: a bioinorganic chemist's perspective. Inorganica Chimica Acta 361 (2008) 875-884
24. Riederer P., and Lachenmayer L. Selegiline's neuroprotective capacity revisited. J. Neural Transm. 110 (2003) 1273-1278
25. Rodriguez-Gomez J.A., Venero J.L., Vizuete M.L., Cano J., and Machado A. Deprenyl induces the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system. Mol. Brain Res. 46 (1997) 31-38
26. Rothblat D.S., and Schneider J.S. The effects of l-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons. Brain Res. 779 (1998) 226-230
27. Spooren W.P.J.M., Waldmeier P., and Gentsch C. The effect of a sub chronic post-lesion treatment with (-)-deprenyl on the sensitivity of 6-OHDA-lesoned rats to apomorphine and d-amphetamine. J. Neural Transm. 106 (1999) 825-833
28. Takeda A., Sotogaku N., and Oku N. Manganese influences the levels of neurotransmitters in synapses in rat brain. Neuroscience 114 3 (2002) 669-674
29. Tatton W.G. Selegiline can mediate neuronal rescue rather than neuronal protection. Mov. Disord. 8 Suppl. 1 (1993) S20-S30
30. Tatton W.G., and Greenwood C.E. Rescue of dying neurons: a new action for deprenyl in MPTP Parkinsonism. J. Neurosci. Res. 30 (1991) 666-672
31. Tatton W.G., Chalmers-Reedman R.M.E., Ju W.J.H., Mammen G.W., Carlile G.W., Pong A.W., and Tatton N.A. Propargylamines induce atiapoptotic new protein synthesis in serum- and nerve growth factor (NGF0-withdrawn, NGF-differentiated PC-12 cells. J. Pharm. Exp. Ther. 301 2 (2002) 753-764
32. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. (suppl) 367 (1971) 69-93
33. Ungerstedt U., and Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 24 (1970) 485-493
34. Valigni F., Pardini C., Cavaletti M., Maggio R., and Corsini G.U. l-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from neurotoxic effect of 1-methyl-4-phenylpyridinium íon. Brain Res. 741 (1996) 68-74
35. Zhao F., Cai T., Liu M., Zheng G., Luo W., and Chen J. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism. Toxicol. Sci. 107 1 (2009) 156-164